ライフサイエンスコーパス: regulatory T-cell

1 ed the precursors of M2 macrophages, DCs and regulatory T cells.

2 tates, including multiple distinct states of regulatory T cells.

3 rtant impacts on the suppressive activity of regulatory T cells.

4 such as myeloid-derived suppressor cells and regulatory T cells.

5 ages, tumor-infiltrating dendritic cells and regulatory T cells.

6 c T-cell engager activated both effector and regulatory T cells.

7 s II-dependent fashion and are suppressed by regulatory T cells.

8 n of gut T cells and an accumulation of skin regulatory T cells.

9 ing less targeted by FOXP3(+) CD4(+) CD25(+) regulatory T cells.

10 ls and loss of intestinal forkhead box p3(+) regulatory T cells.

11 and suppression, which is mediated mainly by regulatory T cells.

12 nt and expansion of ChgA-specific peripheral regulatory T cells.

13 cells and autoimmune-protective human blood regulatory T cells.

14 he induction of therapeutic antigen-specific regulatory T cells.

15 ing of the immune response and inhibition of regulatory T cells.

16 cose metabolism because of maintenance of AT regulatory T cells.

17 ter differentiation of T helper 17 cells and regulatory T cells.

18 t was not sufficient to restore the level of regulatory T cells.

19 engraftment, including an increase in human regulatory T cells.

20 CCL2 induced formation of highly functional regulatory T cells.

21 a transcription factor which is a marker of regulatory T cells.

22 immunity, countering negative regulation by regulatory T cells.

23 ation of atheroprotective immunity involving regulatory T cells.

24 licular helper, T follicular regulatory, and regulatory T cells.

25 cytotoxic T cells and more CD25(+)/FOXP3(+) regulatory T cells.

26 ls (MDSCs) and further decreased circulating regulatory T cells.

27 sitization and anaphylaxis, while sustaining regulatory T cells.

28 necessary for the development of T(H)17 and regulatory T cells.

29 , and a decreased presence of CD4(+)Foxp3(+) regulatory T cells.

30 e deviated toward naive cells with increased regulatory T cells.

31 id cells, which then cross-regulated Th2 and regulatory T cells.

32 and CD8(+) effector T cells and in Foxp3(+) regulatory T cells.

33 , upregulated (median [interquartile range]) regulatory T cells (5.3% [3.1%-18.2%]; P < .05), reduced

34 ns suggest that immune modulators that block regulatory T cell activity may increase responses to vir

35 te counter-regulation by T-helper 1 cell and regulatory T cell activity.

36 oportions of intestinal Foxp3(+)RORgammat(+) regulatory T cells and BALB/c mice developed increased R

37 bers correlated with increased occurrence of regulatory T cells and effector T cells and decreased na

38 immune response by inducing infiltration of regulatory T cells and expression of immune-suppressive

39 that depletes CD25-positive cells including regulatory T cells and has been approved for the treatme

40 n; numerous forkhead box protein P3 (FoxP3)+ regulatory T cells and IgG4 plasma cells; and abundant a

41 The levels of regulatory T cells and IL-10 were elevated at the end of

42 ngside PNA-specific forkhead box P3-positive regulatory T cells and IL-10(+) and TGF-beta1(+) skin-re

43 evels, but the latter preferentially induced regulatory T cells and in general downregulated T cell c

44 expression of CD3(+)/CD4(+)/CD25(+)/FoxP3(+) regulatory T cells and increased the Teff/Treg ratio.

45 cleotidases on various immune cells, such as regulatory T cells and macrophages, as well as component

46 hich may account for the expansion of CD4(+) regulatory T cells and memory-type CD8(+) T cells.

47 possess immunomodulatory potential, in which regulatory T cells and monocytes play a key role.

48 ltration of immune-inhibitory cells, such as regulatory T cells and myeloid-derived suppressor cells,

49 tumour immune microenvironment by decreasing regulatory T cells and myeloid-derived suppressor cells.

50 The TME already shows a reduction in type 1 regulatory T cells and PD-L1+ tumor-associated macrophag

51 scribed correlations between the presence of regulatory T cells and recovery from Lyme arthritis.

52 A small number of regulatory T cells and T helper 1 cells is also identifi

53 However, regulatory T cells and T(H)17 cells were found in higher

54 It acts by attracting regulatory T cells and Th2 cells via their receptor CCR

55 oneal (i.p.) administration of MDP triggered regulatory T cells and the accumulation of a population

56 ited the induction of antigen-specific FoxP3 regulatory T cells and the prevention of food allergy by

57 nction of pro-repair immune cells, including regulatory T cells and tissue macrophages.

58 e role of mTOR in follicular helper T cells, regulatory T cells, and other T cell subsets.

59 otential by regulating macrophage functions, regulatory T cells, and secretion of proresolving mediat

60 ut neither IL-12Rbeta2 nor IL-23R, protected regulatory T cells, and suppressed Th1 and Th17 biasness

61 r function of IL-2 is to maintain functional regulatory T cells, and thus its essential function is i

62 Th2 cells, group 2 innate lymphoid cells and regulatory T cells, and to a lesser extent, on NK cells

63 tment of low HLA-DR expressing monocytes and regulatory T-cells; and transcription of immune checkpoi

64 (regs) treatment and its bystander effect on regulatory T cells are associated with CNS repair as ref

65 These data suggest that pDC-induced regulatory T cells are dependent on downstream signaling

66 ell-DC interaction preferences, and discover regulatory T cells as a major T cell subtype interacting

67 responsive RORgammat-positive FOXp3-positive regulatory T cells as critical for the maintenance of to

68 sion block that can be released by impairing regulatory T cell associated signaling pathways.

69 nce that an elevated proportion of activated regulatory T cells at birth was specific to the sensitiz

70 ed include decreased suppressive activity of regulatory T cells at steady state, which correlates wit

71 Depletion of regulatory T cells at various times after infection also

72 Adipose regulatory T cells (aTregs) have emerged as critical cel

73 latively divergent and CD8+ T cells and CD4+ regulatory T cells being relatively similar.

74 the transcriptional adaptation trajectory of regulatory T cells between lymphoid tissue and colon.

75 as independent of antioxidant mechanisms and regulatory T cells but dependent on residential alveolar

76 TLA-4(+)) and treatment-induced depletion of regulatory T-cells (CD4(+) Foxp3(+)/CTLA-4(+)) was seen

77 eanut-specific clones in the effector versus regulatory T-cell compartment, which distinguished the c

78 l receptor signaling and dysregulated T-cell/regulatory T-cell compartment.

79 trol of alloreactivity and would represent a regulatory T-cell-compatible immunosuppression.

80 pulations of tumor-associated macrophage and regulatory T cell declined.

81 atients received one of six CBMPs containing regulatory T cells, dendritic cells, or macrophages; pat

82 in II-infused mice, suggesting the effect is regulatory T cell-dependent.

83 tive effects of propionate were abrogated in regulatory T cell-depleted angiotensin II-infused mice,

84 vitro stimulation of splenocytes from these regulatory T cell-depleted mice resulted in increases in

85 onset of autoimmune T cell activation after regulatory T cell depletion in an established model of s

86 Regulatory T cell depletion using PC61 antibody was used

87 and proliferative states and no evidence of regulatory T cell depletion.

88 Total T-cell or selective regulatory T-cell depletion abrogates the atheroprotecti

89 TGF-beta activation blocks immunosuppressive regulatory T cell differentiation, which is a potential

90 aralogs during Langerhans cell and inducible regulatory T cell differentiation.

91 -mannose inhibit tumour growth and stimulate regulatory T cell differentiation.

92 n of a transcriptional program that promotes regulatory T-cell differentiation.

93 ell-extrinsic factors, such as nutrients and regulatory T cells, directly and indirectly balance quie

94 nopportune induction of peripherally induced regulatory T cells during immune responses against forei

95 ts who failed withdrawal without evidence of regulatory T cell dysfunction.

96 Depletion of regulatory T cells enhanced response.

97 tively, these findings provide evidence that regulatory T cells existing at the time of, and possibly

98 spring exposed to UFPs, suggesting increased regulatory T cell expression and suppressed Th2/Th17 res

99 y two populations of tTreg, one in which the regulatory T cell fate is associated with unique propert

100 ating T cells mainly displayed exhausted and regulatory T-cell features.

101 ls (p = 0.006), whereas lower proportions of regulatory T cell fractions (p = 0.009), which induce an

102 ividuals, plasma TL1A levels correlated with regulatory T cell frequencies, whereas soluble DR3 was s

103 ther reduced in ALR-H-KO mice; HF/HC reduced regulatory T-cell frequency only in WT mice.

104 e (CD25(+) ) forkhead box P3-positive CD4(+) regulatory T-cell frequency was lower in ALR-H-HET than

105 doleamine-2,3-dioxygenase-1 enzyme activity, regulatory T-cell frequency, activated CD38+Human Leukoc

106 ts of AIT are attributed mainly to increased regulatory T-cell function and increased allergen-specif

107 le of regulatory lymphocyte subsets, such as regulatory T cells, gammadelta regulatory T cells, NKT10

108 ubset strictly equivalent to IL-10-secreting regulatory T cells has only recently been proposed.

109 hymal stromal cells and, to a lesser extent, regulatory T cells have demonstrated efficacy in humans.

110 tion, and the induction of allergen-specific regulatory T cells, highlighting its potential use in th

111 rom the lymphoid compartment promotes a Th17/regulatory T cell imbalance and exacerbates the developm

112 aim was to investigate the role of CCR4 and regulatory T cells in cutaneous wound healing in diabeti

113 ector lymphocytes and a higher activation of regulatory T cells in grafts with subTCMR compared to cT

114 -3 plays an important role in development of regulatory T cells in mice.

115 ease in autoreactive T cells and decrease in regulatory T cells in peripheral tissues.

116 ) PD1(+) CD73(+) ICOS(+) IL-10(+) peripheral regulatory T cells in prediabetic mice, and liposome adm

117 he serum and an increase in the frequency of regulatory T cells in the blood and spleen.

118 growth, increased the ratio of cytotoxic to regulatory T cells in tumors, and prolonged survival.

119 (all CD11c-expressing cells) expands aortic regulatory T cells in vivo, limits the accumulation of T

120 y led to a reduction in AT immunosuppressive regulatory T cells, increased AT CD8(+) T cells, and no

121 Early-relapse tumors have reduced levels of regulatory T cells, increased dendritic cells (DCs), and

122 of IL-10(+) and/or TGF-beta(+)CD4(+)CD25(+) regulatory T cells (induced Treg cells).

123 This was associated with promoting the regulatory T cell-inducing molecule retinoic acid, inhib

124 NFkappaB inhibitors were used to assess the regulatory T-cell induction pathways.

125 Manipulating autoimmunity by inducing regulatory T cells is potentially a more specific and sa

126 king antibody studies suggested that loss of regulatory T cells is the most important cause of aggrav

127 as well as an increase in the frequency of a regulatory T cell, known as Tr1, by week 12 of follow-up

128 were reduced natural killer cells, elevated regulatory T cells, M2-type macrophages, and high PD-L1

129 Expression of the regulatory T cell markers FOXP3 and CD25, together with

130 Assessment of cells bearing regulatory T cell markers from these mice revealed defec

131 -specific immunoglobulins, T-cell cytokines, regulatory T cells, mast cells, and basophils were quant

132 kin was characterized by the accumulation of regulatory T cells, mast cells, M2 macrophages, and mark

133 Moreover, in vitro blockade of regulatory T cell mechanisms of action with biologic mod

134 expression by cDC is not required for CD4(+) regulatory T cell-mediated control of colitis.

135 Here, we demonstrate a role for regulatory T cell-mediated restraint of T(VM) at least i

136 e T-cell responses to interleukin (IL)-2 and regulatory T cell-mediated suppression, the composition

137 Here, we used C57BL/6 "depletion of regulatory T cell" mice to assess the effects these cell

138 However, in mice depleted of regulatory T cells, MPO-Sp administration did not protec

139 Our data suggest that the receptor CCR4 and regulatory T cells negatively affect wound healing in di

140 sets, such as regulatory T cells, gammadelta regulatory T cells, NKT10 cells, and perifollicular mast

141 Furthermore, reducing regulatory T cells or eliminating B and T cells in Rag1

142 tudy consortium after injection of recipient regulatory T cells, or injection of donor regulatory mon

143 sLeX(+)CD4(+)T cells exclusively contain the regulatory T cell population (CD127(low)CD25(high) and F

144 he severity of psoriasis linked to a reduced regulatory T cell population and increased IL-17A expres

145 Cord blood regulatory T-cell populations were measured at birth.

146 sion was identified within effector, but not regulatory T-cell populations.

147 g in the balance between proinflammatory and regulatory T cells potentially favoring a proinflammator

148 e LAMP3 + DC subgroup may be able to recruit regulatory T cells, potentially taking part in the forma

149 s (Th17s) predict improved survival, whereas regulatory T cells predict poorer survival.

150 Regulatory T cells, previously shown to associate with p

151 We showed that depletion of regulatory T cells prior to infection with B. burgdorfer

152 Peripheral induced regulatory T cells (pTreg cells) play a central role in

153 anistically, GM-CSF had no adverse effect on regulatory T-cell reconstitution, but linked adaptive to

154 Regulatory T-cell-related mediators (IL-10 and FOXP3) we

155 er central memory T cell response, and lower regulatory T cell response, compared with controls.

156 A sustained regulatory T-cell response, after IT cessation, occurs i

157 nked to the acquisition and maintenance of a regulatory T-cell response.

158 Although the frequency of regulatory T cells seemed normal in the ELGAN/ELBW prete

159 Furthermore, SLIT enhanced proportions of regulatory T cells specific to RGP.

160 However, the expression of Foxp3, regulatory T cell-specific transcription factor, was enh

161 per cell 17, CD8+ effector, CD4+ memory, and regulatory T-cell-specific signatures.

162 Follicular regulatory T (Tfr) cells are a regulatory T cell subset that controls antibody producti

163 ies of a majority of CD4(+) conventional and regulatory T cell subsets; in general, Ag-naive subsets

164 gulatory over effector T cells, expansion of regulatory T-cell subsets expressing CXCR3 or retinoic a

165 with the presence of functional effector and regulatory T-cell subsets with diverse T-cell receptor c

166 L-17 is tumorigenic in many cancer types and regulatory T cells suppress antitumor T cells.

167 tor expression patterns that interfered with regulatory T-cell suppression assays and were associated

168 ction of both conventional CD4(+) T cell and regulatory T cell (T(reg)) compartments.

169 fic CD4(+) T cells with an atheroprotective, regulatory T cell (T(reg)) phenotype in healthy individu

170 T cell (T(eff)) functions(14,15) and hamper regulatory T cell (T(reg)) suppression(16-20).

171 ng distinct T cell compartments, and several regulatory T cell (T(reg))-biasing anti-IL-2 antibodies

172 Adipose tissue (AT) regulatory T cells (T regs) control inflammation and met

173 42 directly targets Tgfbr1 for repression in regulatory T cells (T(REG) ).

174 programs that generate a broad repertoire of regulatory T cells (T(reg) cells) able to respond to bot

175 Foxp3(+) regulatory T cells (T(reg) cells) are crucial for the ma

176 Regulatory T cells (T(reg) cells) can activate multiple

177 Regulatory T cells (T(reg) cells) play a pivotal role in

178 Regulatory T cells (T(reg) cells) restrict immune system

179 Depleting regulatory T cells (T(reg) cells) to counteract immunosu

180 Regulatory T cells (T(reg) cells), a distinct subset of

181 Regulatory T cells (T(reg) cells), whose differentiation

182 ne receptor 4 (CCR4) is broadly expressed on regulatory T cells (T(reg)) as well as other circulating

183 Recruitment of suppressive CD4(+) FOXP3(+) regulatory T cells (T(reg)) to the tumor microenvironmen

184 nd reduced proportion of SARS-CoV-2-reactive regulatory T cells (T(REG)).

185 lated to improved prognosis is a decrease in regulatory T cells (T(reg)).

186 CD4(+)Foxp3(+) regulatory T cells (T(regs)) are a key cell population c

187 Regulatory T cells (T(regs)) maintain peripheral self-to

188 neonatal Tgammadelta17 cells are innate skin regulatory T cells that are critical for skin homeostasi

189 ast in part by generation of IL-10-secreting regulatory T cells that mediate bystander immunosuppress

190 ably the retinoic orphan receptor gamma T(+) regulatory T cells, the epithelial barrier, and healthy

191 is, where it controls immunity by recruiting regulatory T cells to dendritic cells (DCs).

192 romotes the differentiation of ROR-gammat(+) regulatory T cells to suppress FA.

193 Nrp1 also helps migrate thymus-derived regulatory T cells to vascular endothelial growth factor

194 ) regulatory T cells (Treg cells) and type 1 regulatory T cells (Tr1 cells), concomitant with a reduc

195 that results from mutations in the canonical regulatory T cell transcription factor FOXP3.

196 eing evaluated for T1D is the restoration of regulatory T cell (Treg) activity, specifically directed

197 eta-specific signaling in TGF-beta-dependent regulatory T cell (Treg) differentiation.

198 IL-2R signaling is essential for regulatory T cell (Treg) function.

199 ription factor Foxp3 specifies and maintains regulatory T cell (Treg) identity.

200 interleukin (IL)-6 and IL-2, but peripheral regulatory T cell (Treg) numbers did not increase.

201 he CD4(pos) CD25(high) CD127(neg) FOXP3(pos) regulatory T cell (Treg) pool.

202 cross-sectional study aimed to determine the Regulatory T cell (Treg) properties, together with 14 pl

203 well as a decrease in intratumoral MDSC and regulatory T cell (Treg).

204 Increasing donor graft regulatory T cell (Treg):effector T cell (Teff) ratios c

205 he expansion of MOG(35-55)-specific FoxP3(+) regulatory T cells (Treg cells) and type 1 regulatory T

206 Regulatory T cells (Treg cells) are important for preven

207 required for the development and function of regulatory T cells (Treg cells).

208 ed with expansion of peripheral Foxp3CD4CD25 regulatory T cells (Treg) and increased forkhead box P3

209 athway reduced the intratumoral abundance of regulatory T cells (Treg) and the expression of the Treg

210 CD4(+) Foxp3(+) regulatory T cells (Treg) are essential to maintain immu

211 Whether and how regulatory T cells (Treg) are involved in this postsepti

212 d detect whether the helper T cells (Th) and regulatory T cells (Treg) could affect osteoclasts and f

213 ofiles, and differing capacities to increase regulatory T cells (Treg) during coculture assays, featu

214 Regulatory T cells (Treg) have proven to be a powerful i

215 the latter is due to selective depletion of regulatory T cells (Treg) in a tumor microenvironment.

216 nged with Ova in vitro, though the number of regulatory T cells (Treg) in the LN remained comparable.

217 ntained by the differentiation and action of regulatory T cells (Treg) specific for tissue Ags.

218 ts, with significantly reduced donor-derived regulatory T cells (Treg), increased cytotoxic effector

219 l transplantation, but they induce long-term regulatory T cells (Treg)-dependent graft acceptance onl

220 myeloid-derived suppressor cells (MDSC), and regulatory T cells (Treg).

221 In previous studies, deficits in regulatory T-cell (Treg) number and function at birth ha

222 Antibody levels, regulatory T-cell (Treg) numbers, and cytokine levels we

223 Further, highly immunosuppressive regulatory T cells (Tregs) (ie, ICOShigh/PD-1-) and myel

224 une cells including activated CD4(+)Foxp3(+) regulatory T cells (Tregs) and CD4(+)Foxp3(-) convention

225 ated with expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells (Tregs) and enhanced transforming gro

226 Surprisingly, the levels of regulatory T cells (Tregs) and interleukin-10 (IL-10) we

227 observed between relative counts of FOXP3(+) regulatory T cells (Tregs) and lung cancer risk, and sig

228 eatment also increases the percentage of the regulatory T cells (Tregs) and maintains immune toleranc

229 regulatory myeloid cells (Mregs) that expand regulatory T cells (Tregs) and suppress effector T cells

230 Regulatory T cells (Tregs) are a lymphocyte subset with

231 FOXP3+CD4+ regulatory T cells (Tregs) are critical for immune homeo

232 Regulatory T cells (Tregs) are crucial mediators of immu

233 Regulatory T cells (Tregs) are crucial mediators of immu

234 Regulatory T cells (Tregs) are essential for establishin

235 Regulatory T cells (Tregs) are non-redundant mediators o

236 Foxp3+ regulatory T cells (Tregs) are potent immunoregulatory c

237 Foxp3+ regulatory T cells (Tregs) are potent suppressor cells,

238 In this study, we report that Foxp3(+) regulatory T cells (Tregs) are the main target cells of

239 ivo and are able to increase the function of regulatory T cells (Tregs) at well-tolerated concentrati

240 mIL-2/CD25 acts not only to expand regulatory T cells (Tregs) but also to increase their ac

241 for HIV cure cannot be discarded.IMPORTANCE Regulatory T cells (Tregs) can decisively contribute to

242 To test if Ag-independent stimulation of regulatory T cells (Tregs) can prevent T1D onset, groups

243 Depletion of regulatory T cells (Tregs) delayed spontaneous pain reco

244 Human regulatory T cells (Tregs) have been implicated in cance

245 Regulatory T cells (Tregs) have been shown to be atherop

246 Although regulatory T cells (Tregs) have been studied for their r

247 CD8 regulatory T cells (Tregs) have enhanced apoptosis in ea

248 Regulatory T cells (Tregs) have unique immunosuppressive

249 , we found that the upregulation of Foxp3(+) regulatory T cells (Tregs) in the mesothelioma tumor mic

250 for uterine tropism, we explored the role of regulatory T cells (Tregs) in the pathogenesis of Brucel

251 shown to selectively expand CD4(+)Foxp3(+) T regulatory T cells (Tregs) in vivo.

252 be-induced population of RORgamma-expressing regulatory T cells (Tregs) is essential in controlling g

253 The equilibrium of T-helper 17 (Th17) and regulatory T cells (Tregs) is often found altered in pat

254 ciated toxicity and expansion of suppressive regulatory T cells (Tregs) limit its use in patients wit

255 Regulatory T cells (Tregs) may be key contributors to th

256 eous and systemic accumulation of Foxp3(+) T regulatory T cells (Tregs) partially at the expense of m

257 Regulatory T cells (Tregs) play a central role in the in

258 Regulatory T cells (Tregs) play essential roles in obesi

259 Regulatory T cells (Tregs) play important roles in limit

260 , functional imbalance of Th17 effectors and regulatory T cells (Tregs) promote inflammatory diseases

261 ntional T cells (Tcon) and immunosuppressive regulatory T cells (Tregs) remains elusive.

262 t cells, substantially increase the ratio of regulatory T cells (Tregs) to allo-activated Tconvs, and

263 The potential for regulatory T cells (Tregs) to limit disease progression

264 mma(+) effector Th1 cells and CD4(+)Foxp3(+) regulatory T cells (Tregs) were evaluated by flow cytome

265 ition of B cell depletion to the transfer of regulatory T cells (Tregs) with indirect alloresponse fu

266 Exhausted T and NK cells, regulatory T cells (Tregs), alternatively activated macr

267 genic potential, lower frequency of Foxp3(+) regulatory T cells (Tregs), and increased number of CD8(

268 +)) T cells, CD8(+) T cells, CD4(+) T cells, regulatory T cells (Tregs), gammadelta T cells, B cells,

269 For instance, FOXP3-expressing regulatory T cells (Tregs), have shown remarkable effect

270 Regulatory T cells (Tregs), in contrast, demonstrated an

271 articular effector/memory subsets, including regulatory T cells (Tregs), which also displayed hardwir

272 However, the effect of SP on regulatory T cells (Tregs), which are functionally impai

273 A unique population of regulatory T cells (Tregs), with a distinct transcriptio

274 the checkpoint inhibitory protein CTLA-4 in regulatory T cells (Tregs).

275 n neonates via induction of antigen-specific regulatory T cells (Tregs).

276 ecipients expanded their endogenous Foxp3(+) regulatory T cells (Tregs).

277 hown to regulate immune responses and induce regulatory T cells (Tregs).

278 H to increase the number of bone marrow (BM) regulatory T cells (Tregs).

279 gen controls the selection of autoimmune and regulatory T cells (Tregs).

280 inst hematopoietic stem/progenitor cells and regulatory T-cells (Tregs) deficiency.

281 lios(+), GITR(+), LAG3(+) CD4 T cells (i.e., regulatory T cells [Tregs]).

282 Thymic regulatory T cells (tTreg) are critical in the maintenan

283 cytometry for presence of ovalbumin-specific regulatory T cells, using activation markers, FoxP3, and

284 bset, it accounted for more than 25% of CD4+ regulatory T-cell variation and over 50% of CD8+ central

285 At birth, a higher proportion of activated regulatory T cells was associated with ST (OR = 2.89, 95

286 The frequency of circulating FoxP3 regulatory T cells was not altered.

287 A decrease in the population of CD4+ regulatory T cells was observed during UB-421 monotherap

288 ge-dependent expansion of ovalbumin-specific regulatory T cells was only observed in infants who (a)

289 The proportion of regulatory T cells was reduced in mice born by CS, where

290 ed by markers associated with exhaustion and regulatory T cells, was explored by flow cytometry.

291 To generate MPO-specific regulatory T cells, we used a modified protein-conjugati

292 In contrast, FoxP3(+) regulatory T cells were equally upregulated by transfer

293 n of suppressive molecules, and induction of regulatory T cells were monitored.

294 ers of FoxP3(+) and FoxP3(-) IL-10-secreting regulatory T cells were reduced.

295 were significantly lower, and pro-cancerous regulatory T cells were significantly higher in Late tum

296 ing RORgammat(+) T(reg) cells and follicular regulatory T cells, were c-Maf dependent.

297 genic phenotype and promote the expansion of regulatory T cells, whereas no such effects are seen wit

298 ycosylated antigens also expanded functional regulatory T cells, which are necessary for the durable

299 peripheral homeostasis of Foxp3(+)Helios(+) regulatory T cells, which likely accounts for our findin

300 ant reductions in numbers of CD4(+) Foxp3(+) regulatory T cells within tumors.